The use of psychotropic medication in the management of problem behaviors in the patient with Alzheimer's disease.
Although a variety of potential alternatives to the neuroleptics in the management of agitated behavior in Alzheimer's disease exist, more large, well-controlled studies are needed. At present, neuroleptics remain the standard treatment for this problem. It is also important for the clinician to investigate thoroughly underlying instigators of behavior change in Alzheimer's patients, such as delirium, anxiety, depression, or environmental factors, and target treatment to these disorders.
Sky
A J
AJ
Department of Psychiatry and Human Behavior, Saint Louis University School of Medicine, Missouri.
Grossberg
G T
GT
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000544:Alzheimer Disease / Q000523:psychology*; D000927:Anticonvulsants / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000927:Anticonvulsants; D011619:Psychotropic Drugs; D017366:Serotonin Receptor Agonists; D001569:Benzodiazepines; D008094:Lithium